 MENLO PARK, Calif., Jan. 20, 2021 GLOBE NEWSWIRE -- CohBar, Inc. NASDAQ: CWBR, a clinical stage biotechnology company developing mitochondria based therapeutics to treat chronic diseases and extend healthy lifespan, announced today that its Chief Executive Officer, Steven Engle, will present a company overview at the 3rd Annual Longevity Therapeutics Conference, being held virtually on January 26 - 28, 2021. This presentation will be available for registered attendees at 12:15PM PT on Thursday, January 28, 2021. 